Finalize the basis for allotment of shares of Supriya Lifescience IPO Expected to be held on Thursday, December 23, 2021 and if allotted, the shares will be credited to the demat account of the bidders on December 27. The company’s shares are expected to be listed next week on Tuesday, December 28. Stock Exchanges NSE and BSE.
The three-day initial public offering (IPO) of Supriya Lifescience Ltd was subscribed 71.51 times on the last day of the share sale on Monday. Bids were received for 1,03,89,57,138 shares as against 1,45,28,299 shares in the initial share sale. The price cap for the issue was fixed 265-274 per share.
The registrar link for this IPO is Intime India Pvt Ltd, hence the bidders who have applied for the public issue can check the status of their respective application online on the website of the registrar. Here or on BSE website Here,
The latest issue in the initial share sale of Supriya Lifescience was 200 crore and offer for sale 500 crores. its price range was 265-274 per share. the company had taken 315 crore from anchor investors before its IPO.
The issue got fully subscribed within a few hours on the first day of subscription open on 16th December. The proceeds from the fresh issue will be used to finance capital expenditure requirements, debt repayment and general corporate purposes.
According to market experts, the shares of Supriya Lifescience have been rising. 85 premium in gray market (GMP). Gray market is an unofficial platform where trading starts after the announcement of IPO price band till the listing of shares.
Supriya Lifescience is one of the leading Indian manufacturers and suppliers of active pharmaceutical ingredients, focusing on research and development. As of October 31, 2021, the company had product offerings of 38 APIs focused on diverse therapeutic segments such as Antihistamine, Analgesic, Anesthetic, Vitamin, Anti-Asthma and Anti-Allergy.
Never miss a story! Stay connected and informed with Mint.
download
Our App Now!!
,